News about Industrial talks

Royal Philips Tops EPO MedTech Patent Rankings, Reinforces Innovation Leadership

Royal Philips Tops EPO MedTech Patent Rankings, Reinforces Innovation Leadership

Royal Philips has secured the top position among medical technology companies in the European Patent Office’s (EPO) Technology Dashboard 2025, underscoring its continued leadership in health technology innovation.

Industrial talks | 26/03/2026 | By Darshana |  194

CDR-Life Hits First Milestone in Boehringer Ingelheim Autoimmune Deal

CDR-Life Hits First Milestone in Boehringer Ingelheim Autoimmune Deal

CDR-Life has achieved its first milestone in its partnership with Boehringer Ingelheim, advancing an antibody-based programme targeting autoimmune diseases.

Industrial talks | 24/03/2026 | By News Bureau |  187

194 Drug Samples Fail Quality Tests, CDSCO Flags 4 as Spurious in February Review

194 Drug Samples Fail Quality Tests, CDSCO Flags 4 as Spurious in February Review

Central Drugs Standard Control Organisation has identified 194 drug samples as “Not of Standard Quality” (NSQ) during its routine monthly surveillance for February 2026, while four additional samples have been flagged as spurious.

Industrial talks | 24/03/2026 | By Darshana |  584

Illumina, Labcorp Expand Partnership to Boost Access to Precision Oncology Testing

Illumina, Labcorp Expand Partnership to Boost Access to Precision Oncology Testing

Illumina and Labcorp deepen collaboration to expand next-generation sequencing-based cancer testing, improve access to biomarker diagnostics, and accelerate development of precision oncology solutions.

Industrial talks | 19/03/2026 | By News Bureau |  244

NIPER Raebareli Signs MoU with Roche Pharma India to Boost Pharma Education and Research

NIPER Raebareli Signs MoU with Roche Pharma India to Boost Pharma Education and Research

NIPER Raebareli partners with Roche Pharma India to launch regulatory training, industry lectures and AI-driven research initiatives, strengthening academia-industry collaboration in India’s pharmaceutical sector.

Industrial talks | 18/03/2026 | By News Bureau |  154

GNIP Hosts National Conference on Next-Gen Pharma Trends, Aligns Industry Vision with 'Viksit Bharat'

GNIP Hosts National Conference on Next-Gen Pharma Trends, Aligns Industry Vision with 'Viksit Bharat'

The Guru Nanak Institute of Pharmacy (GNIP), located in Dalewal, Hoshiarpur district, Punjab, hosted a two-day national conference focused on the theme ‘Next-Gen Pharma Trends towards Viksit Bharat.’

Industrial talks | 17/03/2026 | By Darshana

National Institutes of Health Develops AI Tool to Predict Risk of Intimate Partner Violence

National Institutes of Health Develops AI Tool to Predict Risk of Intimate Partner Violence

Researchers funded by National Institutes of Health have developed an AI-based clinical decision tool that predicts risk of Intimate Partner Violence using routine healthcare data with high accuracy.

Industrial talks | 17/03/2026 | By News Bureau |  178

Middle East Conflict Disrupts Pharma Air Routes, Threatens Supply Of Cancer Drugs

Middle East Conflict Disrupts Pharma Air Routes, Threatens Supply Of Cancer Drugs

The ongoing conflict in the Middle East is disrupting critical air cargo routes used to transport pharmaceutical products, raising concerns about the timely supply of cancer medicines and other temperature-sensitive treatments to the Gulf region.

Industrial talks | 16/03/2026 | By Darshana |  186

Central Drugs Standard Control Organisation Issues Advisory Against Promotion of GLP-1 Drugs for Obesity Through Surrogate Advertising

Central Drugs Standard Control Organisation Issues Advisory Against Promotion of GLP-1 Drugs for Obesity Through Surrogate Advertising

India’s drug regulator Central Drugs Standard Control Organisation warns pharmaceutical firms against direct or indirect promotion of prescription-only GLP-1 drugs for obesity, stressing strict compliance with the Drugs and Cosmetics Act, 1940.

Industrial talks | 13/03/2026 | By News Bureau |  192

Symbiosis Pharmaceutical Services Appoints Joanne Anderson as Chief Commercial Officer

Symbiosis Pharmaceutical Services Appoints Joanne Anderson as Chief Commercial Officer

Symbiosis Pharmaceutical Services has appointed Joanne Anderson as CCO, tasking her with leading global commercial strategy as the CDMO expands capacity and strengthens presence across North America and Europe.

Industrial talks | 13/03/2026 | By News Bureau |  189

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members